Clinical trial

Effect of Physical ACtivity in Fingolimod Treated patiEnts (PACE) With Relapsing-remitting Multiple Sclerosis

NCT01490840

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2011-11-01

PhasePHASE4

Study timeline

Study start (unknown)2011-11-01Date precision: month

Registry last updated2016-05-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Fatigue in Multiple Sclerosisunresolved

Interventions

Physical exerciseOTHER

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

BerlinGermany5 HamburgGermany1 HeidelbergGermany1 FrankfurtGermany1 ErlangenGermany1 BochumGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01490840 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.